Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword.

COVID-19 SARS-CoV-2 immunoregulation intestinal microbiota metformin type 2 diabetes

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
25 02 2022
Historique:
received: 26 12 2021
revised: 06 02 2022
accepted: 24 02 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

Coronavirus disease 2019, or COVID-19, is a major challenge facing scientists worldwide. Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by COVID-19. The dysbiotic modulations in the intestine influence the disease severity, potentially due to the ability of the intestinal microbiota to modulate T lymphocyte functions, i.e., to suppress or activate T cell subpopulations. The interplay between the lungs and intestinal microbiota is named the gut-lung axis. One of the most usual comorbidities in COVID-19 patients is type 2 diabetes, which induces changes in intestinal microbiota, resulting in a pro-inflammatory immune response, and consequently, a more severe course of COVID-19. However, changes in the microbiota in this comorbid pathology remain unclear. Metformin is used as a medication to treat type 2 diabetes. The use of the type 2 diabetes drug metformin is a promising treatment for this comorbidity because, in addition to its hypoglycemic action, it can increase amount of intestinal bacteria that induce regulatory T cell response. This dual activity of metformin can reduce lung damage and improve the course of the COVID-19 disease.

Identifiants

pubmed: 35336884
pii: v14030477
doi: 10.3390/v14030477
pmc: PMC8955861
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Science. 2015 Aug 28;349(6251):989-93
pubmed: 26160380
Front Nutr. 2021 Sep 07;8:674258
pubmed: 34557509
Nat Commun. 2016 Nov 14;7:13329
pubmed: 27841267
Cell. 2015 Oct 8;163(2):367-80
pubmed: 26411289
Infect Immun. 2015 Oct;83(10):4003-14
pubmed: 26216419
Immunity. 2009 Apr 17;30(4):471-2; author reply 472-3
pubmed: 19371709
Front Microbiol. 2017 Sep 22;8:1765
pubmed: 29018410
Immunity. 2019 May 21;50(5):1276-1288.e5
pubmed: 30902637
Immunity. 2007 Jul;27(1):145-59
pubmed: 17613255
Nat Commun. 2021 Jun 14;12(1):3611
pubmed: 34127673
Int J Infect Dis. 2021 Dec;113:300-307
pubmed: 34517046
Immunol Invest. 2016;45(3):205-22
pubmed: 27018846
Nat Med. 2008 Mar;14(3):282-9
pubmed: 18264109
Immunity. 2011 May 27;34(5):794-806
pubmed: 21596591
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Mediators Inflamm. 2018 Mar 11;2018:9830939
pubmed: 29713241
Nat Rev Immunol. 2007 Mar;7(3):231-7
pubmed: 17318234
Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):223-237
pubmed: 32076145
Front Immunol. 2020 Jan 15;10:3107
pubmed: 32010146
Br J Nutr. 2016 Jul;116(1):80-93
pubmed: 27151248
Clin Nutr. 2020 Dec;39(12):3618-3628
pubmed: 32340903
Gut. 2022 Jan;71(1):222-225
pubmed: 33833065
Diabetes Care. 2017 Jan;40(1):54-62
pubmed: 27999002
Clin Immunol. 2018 Dec;197:77-85
pubmed: 30218707
Diabetes Care. 2014 Aug;37(8):2343-50
pubmed: 24824547
Nature. 2019 Jan;565(7741):600-605
pubmed: 30675064
Int J Endocrinol. 2021 Apr 1;2021:7394378
pubmed: 33859687
Endocr Pract. 2020 Oct;26(10):1186-1195
pubmed: 33471720
Clin Exp Immunol. 2010 Feb;159(2):109-19
pubmed: 19912252
Nutrients. 2015 Apr 14;7(4):2839-49
pubmed: 25875123
Endocrine. 2019 Dec;66(3):485-493
pubmed: 31410749
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):147-157
pubmed: 32391658
Front Immunol. 2017 Nov 27;8:1632
pubmed: 29230216
Diabetes Obes Metab. 2003 Mar;5(2):120-5
pubmed: 12630937
Diabetologia. 2011 Feb;54(2):339-49
pubmed: 20972533
J Microbiol Methods. 2017 Apr;135:52-62
pubmed: 28189782
Inflamm Bowel Dis. 2018 Aug 16;24(9):1926-1940
pubmed: 29796620
Lancet. 2007 May 12;369(9573):1627-40
pubmed: 17499605
Cell Host Microbe. 2012 Oct 18;12(4):509-20
pubmed: 22999859
Nature. 2012 Jul 5;487(7405):104-8
pubmed: 22722865
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):643-648
pubmed: 29566907
Diabetologia. 2015 Oct;58(10):2206-17
pubmed: 26224102
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Front Microbiol. 2018 Jun 29;9:1403
pubmed: 30008704
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
J Lipid Res. 2006 Feb;47(2):241-59
pubmed: 16299351
PLoS One. 2013 Aug 27;8(8):e71108
pubmed: 24013136
Diabetes Res Clin Pract. 2020 Jun;164:108183
pubmed: 32360697
Nat Med. 2018 Dec;24(12):1919-1929
pubmed: 30397356
Gut. 2014 May;63(5):727-35
pubmed: 23804561
Nature. 2016 Jul 06;535(7610):75-84
pubmed: 27383982
Biomed Res. 2015;36(1):63-70
pubmed: 25749152
Engineering (Beijing). 2020 Oct;6(10):1178-1184
pubmed: 33520333
Cell Host Microbe. 2014 Apr 9;15(4):413-23
pubmed: 24721570
Gut. 2020 Jun;69(6):1002-1009
pubmed: 32213556
J Immunol. 2011 Jan 15;186(2):1162-72
pubmed: 21169542
Nature. 2015 Dec 10;528(7581):262-266
pubmed: 26633628
Curr Microbiol. 2010 Jul;61(1):69-78
pubmed: 20087741
Curr Drug Targets. 2003 Aug;4(6):493-503
pubmed: 12866664
Science. 2016 May 27;352(6289):1116-20
pubmed: 27230380
Diabetologia. 2019 Jun;62(6):1024-1035
pubmed: 30904939
Biochem Biophys Res Commun. 2018 Jul 2;501(4):1041-1047
pubmed: 29777696
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150
pubmed: 27911839
Front Immunol. 2019 Dec 12;10:2910
pubmed: 31921169
Nature. 2013 Aug 8;500(7461):232-6
pubmed: 23842501
Nat Immunol. 2011 Jan;12(1):5-9
pubmed: 21169997
Genome Biol. 2020 Apr 28;21(1):99
pubmed: 32345342
Cell Rep. 2017 Mar 14;18(11):2566-2575
pubmed: 28297661
Science. 2017 Oct 20;358(6361):359-365
pubmed: 29051379
Front Immunol. 2018 Nov 20;9:2667
pubmed: 30524431
PLoS One. 2018 Mar 29;13(3):e0194171
pubmed: 29596446
Mucosal Immunol. 2017 Jan;10(1):104-116
pubmed: 27118489
Nature. 2016 Jul 06;535(7610):65-74
pubmed: 27383981
Sci Rep. 2016 Aug 08;6:30784
pubmed: 27499025
PLoS One. 2012;7(2):e32094
pubmed: 22363800
Biomed Pharmacother. 2021 Dec;144:112230
pubmed: 34628168
Mucosal Immunol. 2021 Mar;14(2):305-316
pubmed: 33244161
J Diabetes Res. 2018 Nov 8;2018:7457269
pubmed: 30533447
Microorganisms. 2020 Jan 10;8(1):
pubmed: 31936722
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
Gut Microbes. 2018 Mar 4;9(2):155-165
pubmed: 29157127
PLoS One. 2012;7(7):e41079
pubmed: 22844426
Diabetes Care. 2001 Mar;24(3):489-94
pubmed: 11289473
Gut Microbes. 2015 Jul 4;6(4):234-42
pubmed: 26230152
Trends Immunol. 2015 Jan;36(1):3-12
pubmed: 25248463
Circ Res. 2017 Mar 31;120(7):1183-1196
pubmed: 28360349
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
J Immunol Res. 2019 Oct 3;2019:4735040
pubmed: 31687412
Curr Opin Immunol. 2010 Feb;22(1):63-72
pubmed: 20171861
PLoS One. 2014 Oct 21;9(10):e111228
pubmed: 25333938
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9
pubmed: 20566854
Front Physiol. 2013 Jan 31;3:496
pubmed: 23386831
Nat Immunol. 2017 Jul 19;18(8):851-860
pubmed: 28722709
Front Microbiol. 2017 Feb 01;8:114
pubmed: 28203226
EBioMedicine. 2020 Jan;51:102590
pubmed: 31901868
Front Immunol. 2019 Mar 08;10:426
pubmed: 30906299
Endocrinology. 2017 Oct 1;158(10):3369-3385
pubmed: 28977604
Nature. 2008 May 29;453(7195):620-5
pubmed: 18509436
Exp Clin Endocrinol Diabetes. 2018 Feb;126(2):96-101
pubmed: 28954308
Acta Pharmacol Sin. 2016 Aug;37(8):1063-75
pubmed: 27180982
AIMS Public Health. 2021 Oct 26;8(4):720-742
pubmed: 34786431
Science. 2011 Jan 21;331(6015):337-41
pubmed: 21205640
Genome Med. 2016 Apr 27;8(1):51
pubmed: 27122046
Gut. 2014 Sep;63(9):1513-21
pubmed: 24833634
Cell Metab. 2020 Sep 1;32(3):379-390.e3
pubmed: 32652044
Nature. 2008 Oct 9;455(7214):808-12
pubmed: 18716618
J Diabetes Res. 2020 Aug 24;2020:3918723
pubmed: 33062712
Gut Microbes. 2016;7(1):22-39
pubmed: 26939849
Commun Biol. 2020 Sep 4;3(1):485
pubmed: 32887924
Mucosal Immunol. 2011 Jan;4(1):15-21
pubmed: 20944557
Cell Metab. 2020 Mar 3;31(3):445-447
pubmed: 32130878
Science. 2019 Jun 21;364(6446):1179-1184
pubmed: 31221858
Diabetes Technol Ther. 2012 Jan;14(1):35-42
pubmed: 21877913
J Immunol Res. 2017;2017:8450496
pubmed: 29359170
Nat Rev Microbiol. 2017 Jan;15(1):55-63
pubmed: 27694885
Appl Environ Microbiol. 2014 Oct;80(19):5935-43
pubmed: 25038099
Mucosal Immunol. 2012 Jan;5(1):7-18
pubmed: 22089028
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Gut Microbes. 2021 Jan-Dec;13(1):1-15
pubmed: 34100340
Gut. 2016 Mar;65(3):415-425
pubmed: 26045134
Front Microbiol. 2018 Sep 19;9:2147
pubmed: 30283410
Obesity (Silver Spring). 2018 Feb;26(2):351-361
pubmed: 29280312
Nat Med. 2017 Jul;23(7):850-858
pubmed: 28530702
Cell Host Microbe. 2021 Sep 8;29(9):1366-1377.e9
pubmed: 34416161
Int J Food Sci Nutr. 2018 Sep;69(6):729-740
pubmed: 29199483
Gut Pathog. 2013 Aug 13;5(1):23
pubmed: 23941657
J Med Life. 2020 Jan-Mar;13(1):50-55
pubmed: 32341701
Immunology. 2010 Feb;129(2):147-53
pubmed: 19922424
Gastroenterology. 2020 Sep;159(3):944-955.e8
pubmed: 32442562
Cell. 2020 Jan 9;180(1):79-91.e16
pubmed: 31866067
Clin Infect Dis. 2020 Dec 17;71(10):2669-2678
pubmed: 32497191
Int J Mol Sci. 2022 Aug 15;23(16):
pubmed: 36012406
Gut. 2021 Apr;70(4):698-706
pubmed: 33431578
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Microb Pathog. 2017 Oct;111:362-369
pubmed: 28912092
Eur J Endocrinol. 2019 Mar;180(3):165-176
pubmed: 30540558
Nature. 2016 Jul 21;535(7612):376-81
pubmed: 27409811
Diabetes Metab Syndr Obes. 2020 Dec 16;13:5003-5014
pubmed: 33364804
Front Cell Infect Microbiol. 2020 Feb 19;10:9
pubmed: 32140452
Lancet. 2021 Dec 19;396(10267):2019-2082
pubmed: 33189186
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Physiol Genomics. 2020 May 1;52(5):217-221
pubmed: 32275178
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
Immunity. 2014 Jan 16;40(1):128-39
pubmed: 24412617
Immunity. 2016 Apr 19;44(4):875-88
pubmed: 27096318
Sci Adv. 2020 Apr 17;6(16):eaaz3186
pubmed: 32494613
Cell Microbiol. 2018 Dec;20(12):e12966
pubmed: 30329198
Immunity. 2015 Oct 20;43(4):817-29
pubmed: 26488817
Anal Chim Acta. 2021 Apr 1;1152:338267
pubmed: 33648648
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
PLoS One. 2018 Sep 27;13(9):e0204317
pubmed: 30261008
Cell. 2005 Jul 15;122(1):107-18
pubmed: 16009137
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068
Science. 2015 Aug 28;349(6251):993-7
pubmed: 26272906
Nature. 2013 Jun 6;498(7452):99-103
pubmed: 23719380
Front Endocrinol (Lausanne). 2021 Apr 07;12:632335
pubmed: 33897618
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
PLoS One. 2015 Jul 10;10(7):e0126976
pubmed: 26161548
Sci Rep. 2017 Mar 02;7:43522
pubmed: 28252037
Science. 2006 Jun 2;312(5778):1355-9
pubmed: 16741115
Nature. 2016 Jun 08;534(7606):213-7
pubmed: 27279214
Commun Biol. 2021 Apr 13;4(1):480
pubmed: 33850296
Pathogens. 2019 Aug 13;8(3):
pubmed: 31412603
PLoS One. 2014 Feb 19;9(2):e87796
pubmed: 24586292
PLoS One. 2021 Feb 17;16(2):e0247041
pubmed: 33596245

Auteurs

Pavlo Petakh (P)

Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine.
Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.

Iryna Kamyshna (I)

Department of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Majdan Voli 1, 46001 Ternopil, Ukraine.

Andriy Nykyforuk (A)

Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine.

Rouan Yao (R)

Center of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.

John F Imbery (JF)

Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.

Valentyn Oksenych (V)

Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.

Mykhaylo Korda (M)

Department of Medical Biochemistry, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.

Aleksandr Kamyshnyi (A)

Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH